Agios Pharmaceuticals Inc. buy Truist Financial Co.
Start price
24.12.25
/
50%
€23.80
Target price
24.12.26
€32.19
Performance (%)
0.84%
Price
05.03.26
€24.00
Summary
This prediction is currently active. The BUY prediction by Truist_Financial_Co_ for Agios Pharmaceuticals Inc. is nearly unchanged. This prediction currently runs until 24.12.26. The prediction end date can be changed by Truist_Financial_Co_ at any time. Truist_Financial_Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Agios Pharmaceuticals Inc. | -6.977% | -6.977% |
| iShares Core DAX® | -5.868% | -2.496% |
| iShares Nasdaq 100 | 1.660% | 3.513% |
| iShares Nikkei 225® | -6.126% | 2.136% |
| iShares S&P 500 | 0.504% | 2.045% |
Comments by Truist_Financial_Co_ for this prediction
In the thread Agios Pharmaceuticals Inc. diskutieren
Agios Pharmaceuticals (NASDAQ:AGIO) had its price target raised by analysts at Truist Financial Corporation from $32.00 to $38.00. They now have a "buy" rating on the stock.
Ratings data for AGIO provided by MarketBeat
Stopped prediction by Truist_Financial_Co_ for Agios Pharmaceuticals Inc.
Agios Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€23.00
24.11.25
24.11.25
-
24.11.26
24.11.26
4.35%
05.03.26
05.03.26
